The rapid emergence and dissemination of medically-important MDR microbial strains
among developed, developing and underdeveloped countries throughout the world is a realistic
public health concern that need to be seriously and promptly addressed, especially if we were
to consider the ease with which drug susceptible microbial strains gain resistances through
mutation and acquisition of transferable resistance genes, and the positive selective pressure
contributed by the indiscriminate use of antimicrobial agents in the community, health care
institutions, agriculture and industry